Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup

PURPOSE: To determine if incorporation of an additional cytotoxic agent improves overall survival (OS) and progression-free survival (PFS) for women with advanced-stage epithelial ovarian carcinoma (EOC) and primary peritoneal carcinoma who receive carboplatin and paclitaxel. PATIENTS AND METHODS: W...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bookman, Michael A., Brady, Mark F., McGuire, William P., Harper, Peter G., Alberts, David S., Friedlander, Michael, Colombo, Nicoletta, Fowler, Jeffrey M., Argenta, Peter A., De Geest, Koen, Mutch, David G., Burger, Robert A., Swart, Ann Marie, Trimble, Edward L., Accario-Winslow, Chrisann, Roth, Lawrence M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2009
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2668552/
https://ncbi.nlm.nih.gov/pubmed/19224846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.19.1684
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados